Immunomodulatory role of exosome-derived content in pediatric medulloblastoma: a molecular subgroup perspective
Authors:
- Jessica Oliveira de SantisJSJessica Oliveira de Santis
- Graziella Ribeiro de SousaGSGraziella Ribeiro de Sousa
- Rosane Gomes de Paula QueirozRQRosane Gomes de Paula Queiroz
- Marina Ferreira CândidoMCMarina Ferreira Cândido
- Fausto AlmeidaFausto Almeida
- Caroline Patini de RezendeCRCaroline Patini de Rezende
- Patricia Cassia de RuyPRPatricia Cassia de Ruy
- Gabriel Santos AriniGAGabriel Santos Arini
- Beth CoyleBCBeth Coyle
- Philippa WadePWPhilippa Wade
- María Sol BrassescoMBMaría Sol Brassesco
- Carlos Alberto ScrideliCSCarlos Alberto Scrideli
- 17 February 2025
- journal article
- research article
- Published by Springer Nature in Human Cell
- Vol. 38 (2) , 1-8
Abstract
Medulloblastoma (MB) is the most common malignant brain tumor in children, comprising four distinct subgroups: wingless (WNT), sonic hedgehog (SHH), Group 3, and Group 4. MYC amplification and metastatic dissemination are challenges in clinical management, and tumor-associated macrophages (TAMs) play an essential role in these intricate molecular processes. However, the influence of immune cells in MB metastasis and MYC-amp is unclear. Secretion of extracellular vesicles (EVs) has emerged as a pivotal mediator facilitating communication within the tumor microenvironment, orchestrating coordinated responses among immune cells during tumor initiation, progression, and tumor dissemination. Here, we sought to elucidate the role of exosome-derived MBs in promoting specific patterns of TAM polarization across different molecular subgroups of MB cell lines. CIBERSORTx analysis using a single-cell RNA dataset revealed an increase in M0 macrophages and a decreased proportion of M2 macrophages in MB patients with tumor dissemination in the central nervous system (CNS). Cell-derived exosomes were found to secrete high levels of IL-4, IL-10, and TGF-β, indicative of a protumor M2-profile pattern. Moreover, EVs from SHH TP53-mutated, Group 3/4, and MYC-amplified MBs induced dissimilar patterns of TNF-α and/or IL-1β overexpression. This study demonstrates that exosomes from pediatric MBs promote a predominant M2-macrophage phenotype and Group 3, Group 4, SHH TP53-mutated, and MYC-amplified MBs induced a mixed M1/M2 response pattern. These findings shed light on the pivotal role of exosomes in modulating the immune response, potentially contributing to immune escape in this malignant neoplasm.Keywords
Funding Information
- FAPESP: São Paulo Research Foundation (2019/11392-3)
- CAPES: Coordination of Superior Level Staff Improvement (Finance Code 001)
- Fundação de Apoio ao Ensino, Pesquisa e Assistência
This publication has 31 references indexed in Scilit:
- Roles of macrophages in tumor development: a spatiotemporal perspectiveCellular & Molecular Immunology, 2023
- Extracellular vesicles and nanoparticles: emerging complexitiesTrends in Cell Biology, 2023
- Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomasSignal Transduction and Targeted Therapy, 2022
- Therapeutic targeting of “undruggable” MYCEBioMedicine, 2021
- Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modalityCell Reports, 2021
- Exosomes: key players in cancer and potential therapeutic strategySignal Transduction and Targeted Therapy, 2020
- Effect of source animal age upon macrophage response to extracellular matrix biomaterialsJournal of Immunology and Regenerative Medicine, 2018
- Intertumoral Heterogeneity within Medulloblastoma SubgroupsCancer Cell, 2017
- Establishment of a novel human medulloblastoma cell line characterized by highly aggressive stem-like cellsCytotechnology, 2015
- Subtypes of medulloblastoma have distinct developmental originsNature, 2010